Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Willekens

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Emerging Infectious Diseases|June 10, 2021
Autochthonous Cases of Tick-Borne Encephalitis, Belgium, 2020Anke Stoefs, Leo Heyndrickx, Jonathan De Winter, et al.
European Journal of Neurology|November 11, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple SclerosisAnna-Victoria De Keersmaecker, Eline van Doninck, Inez Wens, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 4, 2025
Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease- a survey of the NeuroCOVID-19 task force of the European Academy of NeurologySonja Hochmeister, Martin Rakusa, Elena Moro, et al.
Acta Neurologica Belgica|November 3, 2025
Cognitive functioning in multiple sclerosis with focus on brainstem volumeEline Van Doninck, Anna-Victoria De Keersmaecker, Marie D'hooghe, et al.
Cytotherapy|May 27, 2014
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controlsAmber H Nuyts, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Frontiers in Immunology|April 29, 2024
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trialAnna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
Multiple Sclerosis and Related Disorders|March 15, 2024
Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global CommunityLiesbeth Van Hijfte, Melissa Cambron, Brigitte Capron, et al.
Clinical Neurology and Neurosurgery|July 25, 2013
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosisDirk De Ridder, Frank Van Der Aa, Jan Debruyne, et al.
European Journal of Neurology|August 1, 2024
Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers - An updated European Academy of Neurology consensus statementSaša R Filipović, Serefnur Özturk, Daniel Bereczki, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 24, 2013
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factorsKristof Thewissen, Amber H Nuyts, Nathalie Deckx, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Emerging Infectious Diseases|June 10, 2021
Autochthonous Cases of Tick-Borne Encephalitis, Belgium, 2020Anke Stoefs, Leo Heyndrickx, Jonathan De Winter, et al.
European Journal of Neurology|November 11, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple SclerosisAnna-Victoria De Keersmaecker, Eline van Doninck, Inez Wens, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 4, 2025
Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease- a survey of the NeuroCOVID-19 task force of the European Academy of NeurologySonja Hochmeister, Martin Rakusa, Elena Moro, et al.
Acta Neurologica Belgica|November 3, 2025
Cognitive functioning in multiple sclerosis with focus on brainstem volumeEline Van Doninck, Anna-Victoria De Keersmaecker, Marie D'hooghe, et al.
Cytotherapy|May 27, 2014
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controlsAmber H Nuyts, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
Frontiers in Immunology|April 29, 2024
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trialAnna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
Multiple Sclerosis and Related Disorders|March 15, 2024
Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global CommunityLiesbeth Van Hijfte, Melissa Cambron, Brigitte Capron, et al.
Clinical Neurology and Neurosurgery|July 25, 2013
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosisDirk De Ridder, Frank Van Der Aa, Jan Debruyne, et al.
European Journal of Neurology|August 1, 2024
Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers - An updated European Academy of Neurology consensus statementSaša R Filipović, Serefnur Özturk, Daniel Bereczki, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 24, 2013
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factorsKristof Thewissen, Amber H Nuyts, Nathalie Deckx, et al.
Pageof 8